Facing the crisis: Improving the diagnosis of tuberculosis in the HIV era

Journal of Infectious Diseases

Volumn 196, Issue SUPPL. 1, 2007, Pages

  Perkins, Mark D ^a   Cunningham, Jane ^b  

^a FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; BIOTECHNOLOGY; CONFERENCE PAPER; DIAGNOSTIC TEST; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RATE; MORTALITY; PANDEMIC; PREVALENCE; PRIORITY JOURNAL; SUPERINFECTION; TUBERCULOSIS;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; CULTURE MEDIA; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HIV; HIV INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SEROLOGIC TESTS; TUBERCULOSIS;

EID: 34547628245     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/518656     Document Type: Conference Paper

References (153)

1. Klautau GB, Kuschnaroff TM. Clinical forms and outcome of tuberculosis in HIV-infected patients in a tertiary hospital in Sao Paulo - Brazil. Braz J Infect Dis 2005; 9:464-78.
2. Murray JF. Pulmonary complications of HIV-1 infection among adults living in Sub-Saharan Africa. Int J Tuberc Lung Dis 2005; 9:826-35.
3. Poprawski D, Pitisuttitum P, Tansuphasawadikul S. Clinical presentations and outcomes of TB among HIV-positive patients. Southeast Asian J Trop Med Public Health 2000; 31(Suppl 1):140-2.
4. Pitchenik AE, Rubinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 1985; 131:393-6.
5. Lee MP, Chan JW, Ng KK, Li PC. Clinical manifestations of tuberculosis in HIV-infected patients. Respirology 2000; 5:423-6.
6. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4:97-107.
7. Perkins MD, Conde MB, Martins M, Kritski AL. Serologic diagnosis of tuberculosis using a simple commercial multiantigen assay. Chest 2003; 123:107-12.
8. Apers L, Mutsvangwa J, Magwenzi J, et al. A comparison of direct microscopy, the concentration method and the Mycobacteria Growth Indicator Tube for the examination of sputum for acid-fast bacilli. Int J Tuberc Lung Dis 2003; 7:376-81.
9. Marei AM, El-Behedy EM, Mohtady HA, Afify AF. Evaluation of a rapid bacteriophage-based method for the detection of Mycobacterium tuberculosis in clinical samples. J Med Microbiol 2003; 52:331-5.
10. 18-carboxypropylbetaine and standard N-acetyl-L- cysteine-NaOH processing of respiratory specimens for increasing tuberculosis smear sensitivity in Brazil. J Clin Microbiol 2002; 40:3219-22.
11. Selvakumar N, Rahman F, Garg R, et al. Evaluation of the phenol ammonium sulfate sedimentation smear microscopy method for diagnosis of pulmonary tuberculosis. J Clin Microbiol 2002; 40:3017-20.
12. Bruchfeld J, Aderaye G, Palme IB, et al. Evaluation of outpatients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics. Scand J Infect Dis 2002; 34:331-7.
13. Albert H, Heydenrych A, Brookes R, et al. Performance of a rapid phage-based test, FASTPlaqueTB™, to diagnose pulmonary tuberculosis from sputum specimens in South Africa. Int J Tuberc Lung Dis 2002; 6:529-37.
14. Farnia P, Mohammadi F, Zarifi Z, et al. Improving sensitivity of direct microscopy for detection of acid-fast bacilli in sputum: use of chitin in mucus digestion. J Clin Microbiol 2002; 40:508-11.
15. Crampin AC, Floyd S, Mwaungulu F, et al. Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence. Int J Tuberc Lung Dis 2001; 5:994-9.
16. Harries AD, Chilewani N, Dzinyemba W. Diagnosing tuberculosis in a resource-poor setting: the value of sputum concentrations. Trans R Soc Trop Med Hyg 1998; 92:123.
17. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis 2003; 3:288-96.
18. Bruchfeld I, Aderaye G, Palme IB, Bjorvatn B, Kallenius G, Lindquist L. Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. Trans R Soc Trop Med Hyg 2000; 94:677-80.
19. Elliott AM, Namaambo K, Allen BW, et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis 1993; 74:191-4.
20. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. WHO Report 2004. Geneva: WHO, 2004. Available at: http://www.who.int/tb/publications/global_report/2004/en/index. html. Accessed 2 May 2007.
21. Elliott AM, Halwiindi B, Hayes RJ, et al. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. J Trop Med Hyg 1993; 96:1-11.
22. Mesfin MM, Tesfay W, Tasew TW, Richard MJ. The quality of tuberculosis diagnosis in districts of Tigray region of northern Ethiopia. Ethiop J Health Dev 2005; 19:13-20.
23. Lawson L, Yassin MA, Ramsay A, Emenyonu NE, Squire SB, Cuevas LE. Comparison of scanty AFB smears against culture in an area with high HIV prevalence. Int J Tuberc Lung Dis 2005; 9:933-5.
24. Squire SB, Belaye AK, Kashoti A, et al. 'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? Int J Tuberc Lung Dis 2005; 9:25-31.
25. Madebo T, Lindtjorn B. Delay in treatment of pulmonary tuberculosis: an analysis of symptom duration among Ethiopian patients. MedGenMed 1999:E6.
26. Liam CK, Tang BG. Delay in the diagnosis and treatment of pulmonary tuberculosis in patients attending a university teaching hospital. Int J Tuberc Lung Dis 1997; 1:326-32.
27. Harries AD, Nyirenda TE, Godfrey-Faussett P, Salaniponi FM. Defining and assessing the maximum number of visits patients should make to a health facility to obtain a diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis 2003; 7:953-8.
28. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear negative pulmonary tuberculosis in people living with HIV/AIDS in resource constrained settings: informing urgent policy changes. Lancet 2007; 369:2042-9.
29. Harries AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FM. High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis 2001; 5:1000-5.
30. Apers L, Wijarajah C, Mutsvangwa J, Chigara N, Mason P, van der Stuyft P. Accuracy of routine diagnosis of pulmonary tuberculosis in an area of high HIV prevalence. Int J Tuberc Lung Dis 2004; 8:945-51.
31. Hargreaves NJ, Kadzakumanja O, Whitty CJ, Salaniponi FM, Harries AD, Squire SB. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis 2001; 5:847-54.
32. Friend JH, Mason S, Harries AD, Salaniponi FM, Neuhann F. Management and outcome of TB suspects admitted to the medical wards of a central hospital in Malawi. Trop Doct 2005; 35:93-5.
33. Pronyk PM, Kahn K, Hargreaves JR, et al. Undiagnosed pulmonary tuberculosis deaths in rural South Africa. Int J Tuberc Lung Dis 2004; 8:796-9.
34. Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a west African city. AIDS 1993; 7:1569-79.
35. Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 2002; 6:55-63.
36. Nelson AM, Perriens JH, Kapita B, et al. A clinical and pathological comparison of the WHO and CDC case definitions for AIDS in Kinshasa, Zaire: is passive surveillance valid? AIDS 1993; 7:1241-5.
37. Rana FS, Hawken MP, Mwachari C, et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 2000; 24:23-9.
38. Lanjewar DN, Duggal R. Pulmonary pathology in patients with AIDS: an autopsy study from Mumbai. HIV Med 2001; 2:266-71.
39. d'Arminio Monforte A, Vago L, Gori A, et al. Clinical diagnosis of mycobacterial diseases versus autopsy findings in 350 patients with AIDS. Eur J Clin Microbiol Infect Dis 1996; 15:453-8.
40. Gutierrez EB, Zanetta DM, Saldiva PH, Capelozzi VL. Autopsy-proven determinants of death in HIV-infected patients treated for pulmonary tuberculosis in Sao Paulo, Brazil. Pathol Res Pract 2002; 198:339-46.
41. Wilson D, Nachega J, Morroni C, Chaisson R, Maartens G. Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults. Int J Tuberc Lung Dis 2006; 10:31-8.
42. World Health Organization (WHO). Anti-tuberculosis drug resistance in the world. Report no. 2: prevalence and trends. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. WHO/CDS/TB2000.278. Geneva: WHO, 2000.
43. Campos PE, Suarez PG, Sanchez J, et al. Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerg Infect Dis 2003; 9:1571-8.
44. Ritacco V, Di Lonardo M, Reniero A, et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 1997; 176:637-42.
45. Moll A, Gandhi N, Pawinski R, et al. Identification of a multi-drug-resistant tuberculosis cluster as a cause of death among HIV-co-infected patients in rural South Africa [abstract 795]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver). Alexandria, VA: CROI, 2006.
46. Wright PW, Wallace RJ Jr, Wright NW, Brown BA, Griffith DE. Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteria. J Clin Microbiol 1998; 36:1046-9.
47. Buijtels PC, Petit PL, Verbrugh HA, van Belkum A, van Soolingen D. Isolation of nontuberculous mycobacteria in Zambia: eight case reports. J Clin Microbiol 2005; 43:6020-6.
48. Hagemann P. Fluoreszensfärbung von Tuberkelbakterien mit Auramin. Münch Med Wochenschr 1938; 85:1066-8.
49. Richards OW, Kline EK, Leach RE. Demonstration of tubercle bacilli by fluorescence microscopy. Am Rev Tuberc 1941; 44:255-66.
50. Steingarta KR, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6:570-81.
51. Anthony RM, Kolk AH, Kuijper S, Klatser PR. Light emitting diodes for auramine O fluorescence microscopic screening of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2006; 10:1060-2.
52. Ramsay A, Squire SB, Siddiqi K, Cunningham J, Perkins MD. The bleach microscopy method and case detection for tuberculosis control. Int J Tuberc Lung Dis 2006; 10:256-8.
53. Smithwick RW, Stratigos CB. Acid-fast microscopy on polycarbonate membrane filter sputum sediments. J Clin Microbiol 1981; 13:1109-13.
54. Steingart KR, Ng V, Henry M, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6:664-74.
55. Angeby KA, Alvarado-Galvez C, Pineda-Garcia L, Hoffner SE. Improved sputum microscopy for a more sensitive diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4:684-7.
56. Williams-Bouyer N, Yorke R, Lee HI, Woods GL. Comparison of the BACTEC MGIT 960 and ESP culture system II for growth and detection of mycobacteria. J Clin Microbiol 2000; 38:4167-70.
57. Salfinger M, Pfyffer GE. The new diagnostic mycobacteriology laboratory. Eur J Clin Microbiol Infect Dis 1994; 13:961-79.
58. Kiehn TE. The diagnostic mycobacteriology laboratory of the 1990s. Clin Infect Dis 1993; 17(Suppl 2):S447-54.
59. Roberts GD, Goodman NL, Heifets L, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1983; 18:689-96.
60. Morgan MA, Horstmeier CD, DeYoung DR, Roberts GD. Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol 1983; 18:384-8.
61. Tortoli E, Cichero P, Chirillo MG, et al. Multicenter comparison of ESP Culture System II with BACTEC 460TB and with Lowenstein-Jensen medium for recovery of mycobacteria from different clinical specimens, including blood. J Clin Microbiol 1998; 36:1378-81.
62. Gil-Setas A, Torroba L, Fernandez JL, Martinez-Artola V, Olite J. Evaluation of the MB/BacT system compared with Middlebrook 7H11 and Lowenstein-Jensen media for detection and recovery of mycobacteria from clinical specimens. Clin Microbiol Infect 2004; 10:224-8.
63. Lee JJ, Suo J, Lin CB, Wang JD, Lin TY, Tsai YC. Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int J Tuberc Lung Dis 2003; 7:569-74.
64. Scarparo C, Piccoli P, Rigon A, Ruggiero G, Ricordi P, Piersimoni C. Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimens. Diagn Microbiol Infect Dis 2002; 44:157-61.
65. Chien HP, Yu MC, Wu MH, Lin TP, Luh KT. Comparison of the BACTEC MGIT 960 with Lowenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int J Tuberc Lung Dis 2000; 4:866-70.
66. Rohner P, Ninet B, Metral C, Emler S, Auckenthaler R. Evaluation of the MB/BacT system and comparison to the BACTEC 460 system and solid media for isolation of mycobacteria from clinical specimens. J Clin Microbiol 1997; 35:3127-31.
67. Kocagoz T, Alp A, Albay A. A new rapid non-radioactive medium for culturing mycobacteria, that also enables visually differentiation of mycobacterial growth from contamination [poster]. In: Program and abstracts of the American Society for Microbiology General Meeting. Washington, DC: American Society for Microbiology, 2000.
68. Baylan O, Kisa O, Albay A, Doganci L. Evaluation of a new automated, rapid, colorimetric culture system using solid medium for laboratory diagnosis of tuberculosis and determination of anti-tuberculosis drug susceptibility. Int J Tuberc Lung Dis 2004; 8:772-7.
69. Farnia P, Mohammadi F, Mirsaedi M, et al. Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis. J Clin Microbiol 2004; 42:3324-5.
70. Mejia GI, Castrillon L, Trujillo H, et al. Microcolony detection in 7H11 thin layer culture is an alternative for rapid diagnosis of Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis 1999; 3:138-42.
71. Moore DA, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004; 42:4432-7.
72. Albay A, Kisa O, Baylan O, Doganci L. The evaluation of FAST-PlaqueTB test for the rapid diagnosis of tuberculosis. Diagn Microbiol Infect Dis 2003; 46:211-5.
73. Butt T, Ahmad RN, Kazmi SY, Mahmood A. Rapid diagnosis of pulmonary tuberculosis by mycobacteriophage assay. Int J Tuberc Lung Dis 2004; 8:899-902.
74. Alcaide F, Gali N, Dominguez J, et al. Usefulness of a new mycobacteriophage-based technique for rapid diagnosis of pulmonary tuberculosis. J Clin Microbiol 2003; 41:2867-71.
75. Albert H, Heydenrych A, Brookes R, et al. Performance of a rapid phage-based test, FASTPlaqueTB, to diagnose pulmonary tuberculosis from sputum specimens in South Africa. Int J Tuberc Lung Dis 2002; 6:529-37.
76. Muzaffar R, Batool S, Aziz F, Naqvi A, Rizvi A. Evaluation of the FASTPlaqueTB assay for direct detection of Mycobacterium tuberculosis in sputum specimens. Int J Tuberc Lung Dis 2002; 6:635-40.
77. Kalantri S, Pai M, Pascopella L, Riley L, Reingold A. Bacteriophage-based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta-analysis. BMC Infect Dis 2005; 5:59.
78. Cunningham J, Winfrey W, Perkins MD. Global survey of tuberculosis laboratory services. In: Program and abstracts of the 35th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis 2004; 8:S178.
79. Banchuin N, Wongwajana S, Pumprueg U, Jearanaisilavong J. Value of an ELISA for mycobacterial antigen detection as a routine diagnostic test of pulmonary tuberculosis. Asian Pac J Allergy Immunol 1990; 8:5-11.
80. Araj GF, Fahmawi BH, Chugh TD, Abu-Salim M. Improved detection of mycobacterial antigens in clinical specimens by combined enzyme-linked immunosorbent assay. Diagn Microbiol Infect Dis 1993; 17: 119-27.
81. Choudhry V, Saxena RK. Detection of Mycobacterium tuberculosis antigens in urinary proteins of tuberculosis patients. Eur J Clin Microbiol Infect Dis 2002; 21:1-5.
82. Sumi MG, Mathai A, Reuben S, Sarada C, Radhakrishnan W. Immunocytochemical method for early laboratory diagnosis of tuberculous meningitis. Clin Diagn Lab Immunol 2002; 9:344-7.
83. Chanteau S, Rasolofo V, Rasolonavalona T, et al. 45/47 kilodalton (APA) antigen capture and antibody detection assays for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 2000; 4:377-83.
84. Wallis RS, Perkins M, Phillips M, et al. Induction of the antigen 85 complex of M. tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment. J Infect Dis 1998; 178:1115.
85. Landowski CP, Godfrey HP, Bentley-Hibbert SI, et al. Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis. J Clin Microbiol 2001; 39: 2418-24.
86. Bentley-Hibbert SI, Quan X, Newman T, Huygen K, Godfrey HP. Pathophysiology of antigen 85 in patients with active tuberculosis: antigen 85 circulates as complexes with fibronectin and immunoglobulin G. Infect Immun 1999; 67:581-8.
87. Radhakrishnan W, Mathai A. A dot-immunobinding assay for the laboratory diagnosis of tuberculous meningitis and its comparison with enzyme-linked immunosorbent assay. J Appl Bacteriol 1991; 71: 428-33.
88. Pereira Arias-Bouda LM, Nguyen LN, Ho LM, Kuijper S, Jansen HM, Kolk AH. Development of antigen detection assay for diagnosis of tuberculosis using sputum samples. J Clin Microbiol 2000; 38:2278-83.
89. Cho SN, Shin JS, Kim JD, Chong Y. Production of monoclonal antibodies to lipoarabinomannan-B and use in the detection of mycobacterial antigens in sputum. Yonsei Med J 1990; 31:333-8.
90. Sada ED, Aguilar M, Torres, Herrera T. Detection of lipoarabinomannan as a diagnostic test for tuberculosis. J Clin Microbiol 1992; 30: 2415-8.
91. Hamasur B, Bruchfeld J, Haile M, et al. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods 2001; 45:41-52.
92. Tessema TA, Bjune G, Assefa G, Svenson S, Hamasur B, Bjorvatn B. Clinical and radiological features in relation to urinary excretion of lipoarabinomannan in Ethiopian tuberculosis patients. Scand J Infect Dis 2002; 34:167-71.
93. Tessema TA, Bjune G, Hamasur B, Svenson S, Syre H, Bjorvatn B. Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis. Scand J Infect Dis 2002; 34:97-103.
94. Tessema TA, Hamasur B, Bjun G, Svenson S, Bjorvatn B. Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. Scand J Infect Dis 2001; 33:279-84.
95. Boehme C, Molokova E, Minja F, et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 2005; 99:893-900.
96. Abe C, Hirano K, Tomiyama T. Simple and rapid identification of the Mycobacterium tuberculosis complex by immunochromatographic assay using anti-MPB64 monoclonal antibodies. J Clin Microbiol 1999; 37:3693-7.
97. Hasegawa N, Miura T, Ishii K, et al. New simple and rapid test for culture confirmation of Mycobacterium tuberculosis complex: a multicenter study. J Clin Microbiol 2002; 40:908-12.
98. Hirano K, Aono A, Takahashi M, Abe C. Mutations including IS6110 insertion in the gene encoding the MPB64 protein of Capilia TB-negative Mycobacterium tuberculosis isolates. J Clin Microbiol 2004; 42:390-2.
99. Hillemann D, Rüsch-Gerdes S, Richter E. Application of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis 2005; 9:1409-11.
100. Cole RA, Petersen SK, Mackintosh JA, Harcourt RL, Ristevski D, Harry JL. Identification of M. tuberculosis proteins in the body fluids of tuberculosis patients [poster]. In: Program and abstracts of the 36th World Congress of Lung Health of the International Union Against Tuberculosis and Lung Disease (Paris). Paris: International Union Against Tuberculosis and Lung Disease, 2005.
101. Piersimoni C, Scarparo C. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol 2003; 41:5355-65.
102. Huggett JF, McHugh TD, Zumla A. Tuberculosis: amplification-based clinical diagnostic techniques. Int J Biochem Cell Biol 2003; 35:1407-12.
103. Suffys P, Palomino JC, Cardoso Leão S, et al. Evaluation of the polymerase chain reaction for the detection of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2000; 4:179-83.
104. Iwamoto T, Sonobe T, Hayashi K. Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellular in sputum samples. J Clin Microbiol 2003; 41:2616-22.
105. Boehme CC, Nabeta P, Henastroza P, et al. Operational feasibility of using loop-mediated isothermal amplification (LAMP) for the diagnosis of pulmonary TB in microscopy centers of developing countries. J Clin Microbiol 2007; 45:1936-40.
106. Helb D, Jones M, Paul K, et al. Mycobacterium tuberculosis isolation detection, quantitation, and susceptibility testing in a single hands-free step: integrating rapid sputum processing with real-time PCR [poster 2010]. In: Program and abstracts of Tuberculosis: Integrating Host and Pathogen Biology (Whistler, Canada). Silverthorne, CO: Keystone Symposia, 2005.
107. Botezatu I, Serdyuk O, Potapova G, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem 2000; 46: 1078-84.
108. Goletti D, Cannas A, Chiaccio T, et al. Detection of Mycobacterium tuberculosis transrenal DNA from urine samples of patients with pulmonary TB. In: Program and abstracts of the 35th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (Paris). Paris: International Union Against Tuberculosis and Lung Disease, 2005.
109. Talbot EA, Hay Burgess DC, Hone NM, et al. Tuberculosis serodiagnosis in a predominantly HIV-infected population of hospitalized patients with cough, Botswana, 2002. Clin Infect Dis 2004; 39:e1-7.
110. Pottumarthy S, Wells VC, Morris AJ. A comparison of seven tests for serological diagnosis of tuberculosis. J Clin Microbiol 2000; 38:2227-31.
111. Somi GR, O'Brien RJ, Mfinanga GS, Ipuge YA. Evaluation of the MycoDot test in patients with suspected tuberculosis in a field setting in Tanzania. Int J Tuberc Lung Dis 1999; 3:231-8.
112. Weldingh K, Rosenkrands I, Okkels LM, Doherty TM, Andersen P. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens. J Clin Microbiol 2005; 43:57-65.
113. Laal S, Skeiky YA. Immune-based methods. In: Cole S, Eisenach D, McMurray DN, Jacobs WR, eds. Tuberculosis and the tubercle bacillus. Washington, DC: ASM Press, 2005:71-83.
114. Smith H. What happens to bacterial pathogens in vivo? Trends Microbiol 1998; 6:239-43.
115. Thybo S, Richter C, Wachmann H, et al. Humoral response to Mycobacterium tuberculosis-specific antigens in African tuberculosis patients with high prevalence of human immunodeficiency virus infection. Tuber Lung Dis 1995; 76:149-55.
116. Laal S, Samanich KM, Sonnenberg MG, et al. Surrogate marker of preclinical tuberculosis in human immunodeficiency virus infection: antibodies to an 88-kDa secreted antigen of Mycobacterium tuberculosis. J Infect Dis 1997; 176:133-43.
117. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002; 40:704-6.
118. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4:761-76.
119. Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16:2285-93.
120. Elliott AM, Hurst TJ, Balyeku MN, et al. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study. Int J Tuberc Lung Dis 1999; 3:239-47.
121. Pai M, Menzies R. Interferon-release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007; 44:74-7.
122. McKee M. Giant rats to sniff out tuberculosis. NewScientist.com News Service, 16 December 2003. Available at: http://www.newscientist .com/article/dn4488-giant-rats-to-sniff-out-tuberculosis.html. Accessed 2 May 2007.
123. Deisingh AK, Stone DC, Thompson M. Applications of electronic noses and tongues in food analysis. Int J Food Sci Technol 2004; 39: 587-604.
124. Pavlou AK, Turner AP. Sniffing out the truth: clinical diagnosis using the electronic nose. Clin Chem Lab Med 2000; 38:99-112.
125. Fend R, Kolk AH, Bessant C, Buijtels P, Klatser PR, Woodman AC. Prospects for clinical application of electronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. J Clin Microbiol 2006; 44:2039-45.
126. Fend R, Geddes R, Lesellier S, et al. Use of an electronic nose to diagnose Mycobacterium bovis infection in badgers and cattle. J Clin Microbiol 2005; 43:1745-51.
127. Phillips M, Cataneo RN, Condos R, et al. Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb) 2006; 87: 44-52.
128. Cunningham J, Perkins MD, et al. Diagnostics for tuberculosis: global demand and market potential. Geneva: World Health Organization, 2006.
129. Kertcher JA, Chen MF, Charache P, et al. Rapid radiometric susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis 1978; 117:631-7.
130. da Silva PA, Boffo MM, de Mattos IG, et al. Comparison of redox and D29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2006; 12:293-6.
131. Scarparo C, Ricordi P, Ruggiero G, Piccoli P. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. J Clin Microbiol 2004; 42:1109-14.
132. Kontos F, Maniati M, Costopoulos C, et al. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. J Microbiol Methods 2004; 56:291-4.
133. Albert H, Trollip AP, Mole RJ, Hatch SJ, Blumberg L. Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FAST-PlaqueTB-RIF, a manual phage-based test. Int J Tuberc Lung Dis 2002; 6:523-8.
134. Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J Infect 2005; 51:175-87.
135. Wilson SM, Al-Suwaidi Z, McNerney R, Porter J, Drobniewski F. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med 1997; 3:465-8.
136. Angeby KA, Werngren J, Toro JC, Hedstrom G, Petrini B, Hoffner SE. Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis. Clin Microbiol Infect 2003; 9:1148-52.
137. Bemer P, Palicova F, Rüsch-Gerdes S, Drugeon HB, Pfyffer GE. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2002; 40:150-4.
138. Goloubeva V, Lecocq M, Lassowsky P, Matthys F, Portaels F, Bastian I. Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J Clin Microbiol 2001; 39:1501-5.
139. Tortoli E, Benedetti M, Fontanelli A, Simonetti T. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J Clin Microbiol 2002; 40:607-10.
140. Angeby KAK, Klintz L, Hoffner SE. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 2002; 40:553-5.
141. Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355:1539-50.
142. Albert H, Trollip A, Seaman T, Mole RJ. Simple, phage-based (FASTPplaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum. Int J Tuberc Lung Dis 2004; 8:1114-9.
143. Jacobs WR, Barletta RG, Udani R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993; 260:819-22.
144. Banaiee N, Bobadilla-del-Valle M, Bardarov S, et al. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico. J Clin Microbiol 2001; 39:3883-8.
145. Banaiee N, Bobadilla-del-Valle M, Riska PF, et al. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages. J Med Microbiol 2003; 52:557-61.
146. Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol 2006; 44:4459-63.
147. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006; 44:2485-91.
148. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006; 44: 2338-42.
149. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005; 43:3699-703.
150. Marttila HJ, Soini H, Vyshnevskaya E, et al. Line probe assay in the rapid detection of rifampin-resistant Mycobacterium tuberculosis directly from clinical specimens. Scand J Infect Dis 1999; 31:269-73.
151. Gamboa F, Cardona PJ, Manterola JM, et al. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis 1998; 17:189-92.
152. Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998; 36:1969-73.
153. Rossau R, Traore H, De Beenhouwer H, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997; 41:2093-8.